The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease.
about
Remote magnetic targeting of iron oxide nanoparticles for cardiovascular diagnosis and therapeutic drug delivery: where are we now?Pathogenesis and neuroimaging of cerebral large and small vessel disease in type 2 diabetes: A possible link between cerebral and retinal microvascular abnormalitiesImaging Atherosclerosis.Monitoring the biological activity of abdominal aortic aneurysms Beyond UltrasoundImaging Modalities to Identity Inflammation in an Atherosclerotic Plaque.Vascular and plaque imaging with ultrasmall superparamagnetic particles of iron oxideNon-invasive anatomic and functional imaging of vascular inflammation and unstable plaqueIron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammationNon-invasive imaging of atherosclerosisImaging and nanomedicine in inflammatory atherosclerosisMagnetic resonance coronary angiography: where are we today?Molecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agentsInflammation and neovascularization intertwined in atherosclerosis: imaging of structural and molecular imaging targets.MRI using ultrasmall superparamagnetic particles of iron oxide in patients under surveillance for abdominal aortic aneurysms to predict rupture or surgical repair: MRI for abdominal aortic aneurysms to predict rupture or surgery-the MA(3)RS studyMaintaining brain health by monitoring inflammatory processes: a mechanism to promote successful agingAtherosclerosis and Nanotechnology: Diagnostic and Therapeutic Applications.Imaging atherosclerosis and vulnerable plaque.Molecular imaging of inflammation in atherosclerosis.Improving quantification of intravascular fluorescence imaging using structural information.Emerging diagnostic and therapeutic molecular imaging applications in vascular diseasePerspectives and opportunities for nanomedicine in the management of atherosclerosis.Progress in atherosclerotic plaque imaging.Cardiovascular molecular imaging: focus on clinical translationCardiovascular magnetic resonance in carotid atherosclerotic disease.Effect of glitazones on the progression of coronary artery disease in type 2 diabetes patients.Imaging of atherosclerosisEmerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.Enabling individualized therapy through nanotechnologyMRI of carotid atherosclerosis.Different capacity of monocyte subsets to phagocytose iron-oxide nanoparticlesImaging biomarkers of cardiovascular disease.Imaging of atherosclerosis: magnetic resonance imaging.Molecular imaging of plaques in coronary arteries with PET and SPECT.Contribution of cardiovascular magnetic resonance in the evaluation of coronary arteries.Pioglitazone suppresses inflammation in vivo in murine carotid atherosclerosis: novel detection by dual-target fluorescence molecular imaging.Macrophage targeted theranostics as personalized nanomedicine strategies for inflammatory diseases.Report of the National Heart, Lung, and Blood Institute working group on the translation of cardiovascular molecular imaging.Carotid artery atherosclerosis: effect of intensive lipid therapy on the vasa vasorum--evaluation by using dynamic contrast-enhanced MR imaging.Imaging atherosclerosis with hybrid positron emission tomography/magnetic resonance imagingCardiovascular MRI in clinical trials: expanded applications through novel surrogate endpoints
P2860
Q26739877-D210D8C2-D89B-42AE-A8D4-DB2B0D3B0B1FQ26744840-B3290537-9FA8-4700-BA14-075B12CD077FQ26764836-2BE37E26-B962-43C1-883C-213C87B16231Q26765979-B7E50836-A0A5-49EB-9AA9-4A337BEAF690Q26769824-24383CE2-5301-40D4-A15C-72F87DDEB24BQ26783581-E5178164-20D5-44E2-BA77-72AE9E5BBDD4Q26824883-48713AB7-B25C-4EDC-A64D-960D23C5487EQ26830874-A4B0154E-0A9D-4159-A164-E0641AE3B66DQ26992143-69DABAA6-32C0-4F4E-BBC6-D2B5544246BBQ27002916-FAD6C972-C3E3-46A6-83B8-DADB1B6DAC33Q27003403-5AC9E0F4-FA02-4C80-8ACF-499C4A2573B2Q27027613-24950963-5F3E-43C7-AF27-659F51C19878Q27692593-E6A6B667-2179-405D-BAC7-853A59714E11Q28648415-0F40D481-0C74-4D25-8035-207B83A7FD41Q28730725-518994BF-E063-4BE2-98C5-CF598708FA76Q30364399-68AEB4AA-95A7-4729-87C4-AC8E664BD472Q30435383-6E1803A3-933A-41FD-B672-A2A056422BFAQ30446268-1B3628C7-E0AE-4D52-A2BF-99AC0DA3B664Q30448146-7C073F7E-05EB-4750-BB9C-82E2E29E5506Q30450437-B6C9629B-5995-4ACC-8A49-91863051F16EQ30455490-364344BE-BB11-4DDB-8051-D0299D0F5227Q30464390-AC7C0EE0-8EE3-40DC-B281-285448DA2B27Q30470859-86C530B8-A69B-4DFE-AFE6-70CC6D03CD8CQ33592226-36CD218A-65A0-4DFC-8054-C282EAF90863Q33686312-F56A43EE-5483-41D0-8A2D-8C37FDE51C71Q33697215-010B5994-2227-4711-ACE8-F7EE54527945Q33839384-F68DBF2F-C9F8-4E5A-89C6-3D2C3B8D9C26Q33917755-54D7C24C-60EA-4F76-833A-49B07DBB34CDQ33922492-45CBA071-5122-4449-BACF-4F7A3A8609E3Q34044843-E511297D-E369-4BF3-AF98-E6CB8265B644Q34109961-9647FEFB-D4BF-4600-BB12-9A41F2F063BBQ34179702-96195A26-34DD-47E5-ACCF-21F23597F8A3Q34260475-A4A0E950-479A-41DD-BE29-99D2F7C279BEQ34404461-06E94173-CFBB-41F5-BBC3-F9F9C08FD271Q34537454-680E1AF3-D1B5-4A8D-8C1A-4C10CA17BD13Q34785236-D1B2C877-733E-47E3-8B1C-32850BAC1CE3Q35058188-8D8C90CD-0A89-4630-9BA5-35A2F79E9F18Q35062096-8763BFEE-EAD5-43EC-BE6F-596A39ADA740Q35072987-E499AC26-17F8-4E57-B6CF-B86E49514C6FQ35124348-187D4BD5-FBD0-470F-8F13-C13B3711B667
P2860
The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
The ATHEROMA (Atorvastatin The ...... ce imaging in carotid disease.
@en
The ATHEROMA
@nl
type
label
The ATHEROMA (Atorvastatin The ...... ce imaging in carotid disease.
@en
The ATHEROMA
@nl
prefLabel
The ATHEROMA (Atorvastatin The ...... ce imaging in carotid disease.
@en
The ATHEROMA
@nl
P2093
P50
P1476
The ATHEROMA (Atorvastatin The ...... nce imaging in carotid disease
@en
P2093
Andrew Zalewski
Elizabeth A Warburton
Jean-Marie U-King-Im
Jonathan H Gillard
Jonathan R Boyle
Kevin Varty
Michael E Gaunt
Paul D Hayes
Peter J Kirkpatrick
Sam R Miller
P304
P356
10.1016/J.JACC.2009.03.018
P407
P577
2009-06-01T00:00:00Z